| 23/561 |
Treatment of Dermatological Conditions |
| 23/560 |
Systems for Patient Management & Bed Management and CDR |
| 23/559 |
Hearing Loss Diagnosis in Children |
| 23/558 |
Agency Nurse Usage & Spend |
| 23/556 |
Radiotherapy Waiting Times 2018 - 2023 |
| 23/555 |
Medications for Conditions Including Asthma |
| 23/552 |
Renal Dialysis Capacity |
| 23/551 |
Spend on Agency Radiologists |
| 23/550 |
Electric Scooter Injuries to Children |
| 23/548 |
Organisation Chart - Diagram of Service Areas |
| 23/546 |
Tech Expiry Contract - Virtual Ward & Remote Monitoring System |
| 23/545 |
Haemophilia A Treatment |
| 23/544 |
Specialist Seating for Patients & Fundamental |
| 23/543 |
Agency Nursing Spend 01.04.2023 - 30.06.2023 |
| 23/542 |
Tech Contract Expiry - Kainos Evolve |
| 23/541 |
New Biologic & Targeted Medications Within Dermatology & Respiratory Medicine |
| 23/540 |
Cancer Appointments Cancelled because of Industrial Action |
| 23/533 |
On-Framework & Off-Framework Agency Staff |
| 23/531 |
Usage of Ruxolitinib |
| 23/530 |
Admissions, Discharges & Hospital Beds 2018 - 2023 |
